$DVLT

Datavault AI Inc. (DVLT): Entry into a Material Definitive Agreement

Datavault AI Inc. (DVLT) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 tm2621627d1_ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 Datavault AI Inc. One Commerce Square 2005 Market Street, Suite 2400 Philadelphia, PA 19103 July 29, 2026 EOS Technology Holdings Inc. 48 Wall Street, Floor 11 New York, NY 10005 Attention: Nathaniel Bradley, Chief Execut

Original reporting
Published Jul 30, 2026, 8:02 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 30, 2026, 8:04 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$DVLT
Neutral
medium confidence
Mentioned
$DVLT
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$DVLTNeutralMed
01

Why it matters

The agreement grants the beneficiary discretion to elect share settlement for earnout payments, with share quantity set by a five-day VWAP determination price (with a stated $0.61 for the Dec 31, 2025 earnout period). It also includes a cash reversion right if resale registration is not effective within a specified window.

02

Market read

This is a primary disclosure of earnout settlement mechanics that can affect DVLT’s dilution expectations and settlement cash needs depending on election behavior and registration timing.

03

What to watch

Traders will want the missing parts of the agreement for exchange cap, cash reversion triggers, and the total earnout amount, since those determine how many shares could ultimately be issued.

Relevance 6/10Novelty 6/10Timing: filed today, terms apply to the Dec 31, 2025 earnout settlement election process

Background

The 8-K Item 1.01 describes a letter agreement amending/implementing an existing Earnout Agreement dated Dec 31, 2024 between Datavault AI Inc. and EOS Technology Holdings Inc.

Company-level read

Ticker impact

$DVLTNeutralMedium confidence
Context

DVLT entered an 8-K material definitive agreement letting EOS elect to receive earnout payments in DVLT shares instead of cash, using a VWAP-based determination price.

Expected impact

Likely modest, sentiment-neutral impact unless the earnout size is large or the share-based election becomes widely used.

Evidence & confidence

The disclosure is a primary SEC filing describing earnout share election terms and a specific determination price for the Dec 31, 2025 period ($0.61). However, the excerpt does not quantify total earnout dollars/shares, so magnitude is uncertain.

Market effects

Limited sector read-through; this is company-specific earnout settlement structure rather than an industry-wide change.

None indicated.

None indicated.

Counterpoint

If the cash reversion right is likely to be triggered (registration delays), the practical effect may shift back toward cash, reducing dilution risk.

Key entities

  • Datavault AI Inc.

    Company filing the 8-K and issuing common stock for earnout share settlement.

  • EOS Technology Holdings Inc.

    Beneficiary under the earnout agreement with the right to elect share-based settlement.

  • SEC

    Registration statement effectiveness timing drives the cash reversion right.

Related articles

$DVLTMed

Datavault AI Hit With Securities Lawsuit

Datavault AI Inc. (NASDAQ: DVLT) faces a new securities class action, according to DJS Law Group, alleging the company misled investors about operations, partnerships, and growth prospects. The proposed class period is Sept. 4, 2024 to Oct. 30, 2025. The claims stem largely from a Wolfpack Research report that preceded a ~19% one-day share drop. Lead plaintiff deadline is Oct. 5, 2026.

$DVLTMed

Pomerantz Law Firm Announces the Filing of a Class Action Against Datavault AI Inc. and Certain Officers - DVLT

Pomerantz LLP said it filed a securities class action against Datavault AI Inc. (NASDAQ: DVLT) and certain officers in the Eastern District of Pennsylvania, covering purchases from Sept. 4, 2024 to Oct. 30, 2025. The suit alleges misleading statements about partnerships, trading activity, and compliance. After a Wolfpack Research report on Oct. 31, 2025, DVLT shares fell 19.44% to $2.03.

$DVLTMed

Datavault AI Expands Data Driven Outcome Healthcare

Datavault AI (NASDAQ:DVLT) said it amended its definitive agreement with DataMeds AI (NASDAQ:MEDS) to expand a PharmacyChain blockchain technology licensing relationship into unencumbered commercial healthcare, healthspan and wellness uses. Datavault AI will receive common shares worth about 19.9% of DataMeds’ stock at closing, replacing preferred shares for tax optimization.

$MEDSMed

DataMEDS AI, Inc.: DataMeds AI Expands License with DataVault AI for Data Driven Outcome Healthcare-focused Blockchain and Data Monetization License

DataMeds AI (NASDAQ:MEDS) said it amended its licensing agreement with Datavault AI (NASDAQ:DVLT) to expand PharmacyChain blockchain-related licensing from pharmaceutical distribution to all unencumbered commercial healthcare, healthspan and wellness uses. The deal is tied to a pending multi-party combination and includes DVLT receiving common shares worth about 19.9% of MEDS at closing.